Telix to Acquire US-Based Radiochemistry Firm Optimal Tracers

Excerpt Australia-based Telix Pharmaceuticals has entered into an agreement with Sacramento-based Northern California PET Imaging Center (NCPIC) to acquire Optimal Tracers, a radiochemistry development business providing radiochemistry process development services and research tracers for use in clinical trials. Article Summary The acquisition of Optimal Tracers will bolster Telix’s in-house radiochemistry development capability, by adding a […]

M&A, CGT and Disruptive Drugs Focus for CSL Going Forward

Excerpt Over the past year, CSL has unveiled some big deals that will change the breadth of its focus in a major way. Article Summary The company recently closed an $18.8 billion deal to buy Swiss pharmaceuticals firm Vifor, which makes products for iron deficiency and kidney disease. This was a huge acquisition, and one […]

CSL Brings Next-Gen Vaccines to Australia in $313mn Deal

Excerpt Biotech giant CSL will accelerate investment in messenger-RNA technologies through a $313 million licensing deal with US medicines maker Arcturus Therapeutics, which is developing mRNA vaccines to fight influenza and COVID. Article Summary CSL told investors on Wednesday that its vaccine arm, CSL Seqirus, had inked a deal with Arcturus that would give the […]

Bridgewest Buys Another Pfizer Manufacturing Plant in Australia

Excerpt Two years after acquiring a Pfizer biologics plant in Adelaide, Australia, Bridgewest Group has bought up another Pfizer manufacturing facility in the country. Article Summary The San Diego-based investment firm has agreed to purchase a sterile injectables site near Perth. The facility has extensive blow, fill, seal capabilities and supplies products—including specialty oncology drugs—to […]

Australia to Play Key Role in Moderna’s Next Chapter

Excerpt It’s less than two years since Moderna brought its coronavirus vaccine to the world, but the company’s global chief executive Stephane Bancel has ambitious plans for the company’s next stage of innovation and growth. Article Summary Australia looks set to play a key part in the next chapter of the biotech’s history. After much […]

Provisional Approval of Moderna Boster for Under-12’s byTGA

Excerpt: On 19 October 2022, the Therapeutic Goods Administration (TGA) provisionally approved Moderna’s COVID-19 vaccine, SPIKEVAX (elasomeran), for use as a booster dose in individuals aged 12 years and older.   Article Summary: This mRNA vaccine is already provisionally approved for immunisation to prevent COVID 19 in individuals aged 6 months and older and as […]

NATA Certification Enables BGI Australia to Perform Clinical Whole Exome Sequencing

Excerpt: BGI Australia’s lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing in Australia, paving the way for the global life sciences company to provide clinical sequencing services for identifying possible disease-causing genetic changes.   Article Summary: The lab will start to provide clinical services in […]

Griffith University Joins Forces with LimmaTech Biologics to Develop World-First Gonorrhoea Vaccine

Excerpt: Millions of lives are set to be changed for the better thanks to a landmark deal between Griffith University and Swiss-based company LimmaTech Biologics AG to develop a world-first gonorrhoea vaccine.   Article Summary: Researchers from Griffith’s Institute for Glycomics have developed a suite of vaccine technologies for the prevention of gonorrhoea, and potentially […]

Agilex Biolabs Builds New Facility and Bolsters Team

Excerpt: A toxicology facility with more than 10,000 sq ft of laboratory space has opened in Australia and will help Agilex Biolabs expand its capacity to serve the biotech, pharma and animal health industries.   Article Summary: After more than 25 years in the industry, Agilex Biolabs says it will now be able to share […]

Luina Bio to Rebrand as AcuraBio after Ampersand Capital Partners and Dr. Glenn Haifer Acquisition

Excerpt AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global healthcare private equity firm. Article Summary With more than two decades of experience, AcuraBio is a globally focussed organization bringing innovative therapeutics to market for customers in the biotech, pharmaceutical, […]

Historic $478m Investment to Change Australian Healthcare Forever

Excerpt The University of Sydney announced its largest ever capital investment, a landmark $478 million to build a nation-leading biomedical precinct to fast track research and patient care in New South Wales. The Sydney Biomedical Accelerator (SBA) will create a first-in-Australia, 36,000m2 health, education, and research precinct co-located at Royal Prince Alfred Hospital and the […]

Embryonic Blood Stem Cell Creation Research at The University of New South Wales Could Change the Future of Stem Cell Blood Donation

Excerpt Making stem cells from a patient’s adult cells – rather than human embryos – is one of the holy grails in modern medicine treatments. New research brings us two steps closer. Article Summary Biomedical engineers and medical researchers at UNSW Sydney have independently made discoveries about embryonic blood stem cell creation that could one […]